Literature DB >> 17488904

Short report: rare Plasmodium falciparum merozoite surface protein 1 19-kda (msp-1(19)) haplotypes identified in Mali using high-throughput genotyping methods.

Shannon L Takala1, David L Smith, Mahamadou A Thera, Drissa Coulibaly, Ogobara K Doumbo, Christopher V Plowe.   

Abstract

Genetic diversity in malaria vaccine antigens may compromise malaria vaccine efficacy, so it is important to understand this diversity and the processes that generate it. By applying new high-throughput genotyping methods to a large sample of infections from Mali (N = 1369), seven new 19-kDa merozoite surface protein 1 (MSP-1(19)) haplotypes were identified. Herein we report the sequences of these new haplotypes and discuss their possible origins. Although they are present in < 1% of the samples examined, the existence of these rare haplotypes reveals a greater degree of diversity at this locus than previously reported and highlights the potential for Plasmodium to evolve under selective pressure from the immune system and from such interventions as vaccines and drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488904      PMCID: PMC2740818     

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  34 in total

1.  Two types of sequence polymorphism in the circumsporozoite gene of Plasmodium falciparum.

Authors:  T F McCutchan; A A Lal; V do Rosario; A P Waters
Journal:  Mol Biochem Parasitol       Date:  1992-01       Impact factor: 1.759

2.  Plasmodium falciparum: genetic diversity of C-terminal region of MSP-1 in isolates from Indian sub-continent.

Authors:  S Vijay Kumar; Sarita Ranjan; Vishal Saxena; Vidya Rajesh; S K Roy; Dhanpat Kochar; Akash Ranjan; Ashis Das
Journal:  Exp Parasitol       Date:  2005-08       Impact factor: 2.011

3.  Effects of acquired immunity and mating strategy on the genetic structure of parasite populations.

Authors:  Katrina A Lythgoe
Journal:  Am Nat       Date:  2002-05       Impact factor: 3.926

4.  Anti-merozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: subclass analysis with age, exposure to asexual parasitemia, and protection against malaria. V. The Asembo Bay Cohort Project.

Authors:  O H Branch; A J Oloo; B L Nahlen; D Kaslow; A A Lal
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

5.  Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum.

Authors:  K Tanabe; M Mackay; M Goman; J G Scaife
Journal:  J Mol Biol       Date:  1987-05-20       Impact factor: 5.469

6.  Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

Authors:  L H Miller; T Roberts; M Shahabuddin; T F McCutchan
Journal:  Mol Biochem Parasitol       Date:  1993-05       Impact factor: 1.759

7.  Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria.

Authors:  S Gupta; J Swinton; R M Anderson
Journal:  Proc Biol Sci       Date:  1994-06-22       Impact factor: 5.349

8.  Plasmodium falciparum: gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate.

Authors:  S P Chang; K J Kramer; K M Yamaga; A Kato; S E Case; W A Siddiqui
Journal:  Exp Parasitol       Date:  1988-10       Impact factor: 2.011

9.  A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

Authors:  S P Chang; S E Case; W L Gosnell; A Hashimoto; K J Kramer; L Q Tam; C Q Hashiro; C M Nikaido; H L Gibson; C T Lee-Ng; P J Barr; B T Yokota; G S Hut
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites.

Authors:  A A Holder; M J Lockyer; K G Odink; J S Sandhu; V Riveros-Moreno; S C Nicholls; Y Hillman; L S Davey; M L Tizard; R T Schwarz
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

View more
  5 in total

1.  Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria.

Authors:  Jason A Bailey; Jozelyn Pablo; Amadou Niangaly; Mark A Travassos; Amed Ouattara; Drissa Coulibaly; Matthew B Laurens; Shannon L Takala-Harrison; Kirsten E Lyke; Jeff Skinner; Andrea A Berry; Algis Jasinskas; Rie Nakajima-Sasaki; Bourema Kouriba; Mahamadou A Thera; Philip L Felgner; Ogobara K Doumbo; Christopher V Plowe
Journal:  Am J Trop Med Hyg       Date:  2014-10-06       Impact factor: 2.345

2.  The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.

Authors:  Alexander D Douglas; Andrew R Williams; Joseph J Illingworth; Gathoni Kamuyu; Sumi Biswas; Anna L Goodman; David H Wyllie; Cécile Crosnier; Kazutoyo Miura; Gavin J Wright; Carole A Long; Faith H Osier; Kevin Marsh; Alison V Turner; Adrian V S Hill; Simon J Draper
Journal:  Nat Commun       Date:  2011-12-20       Impact factor: 14.919

3.  Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas.

Authors:  Bright Adu; Mariama K Cherif; Samuel Bosomprah; Amidou Diarra; Fareed K N Arthur; Emmanuel K Dickson; Giampietro Corradin; David R Cavanagh; Michael Theisen; Sodiomon B Sirima; Issa Nebie; Daniel Dodoo
Journal:  Malar J       Date:  2016-02-27       Impact factor: 2.979

4.  The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.

Authors:  Patrick L Sutton; Eva H Clark; Claudia Silva; OraLee H Branch
Journal:  Malar J       Date:  2010-01-04       Impact factor: 2.979

5.  Molecular Evolution of PvMSP3α Block II in Plasmodium vivax from Diverse Geographic Origins.

Authors:  Bhavna Gupta; B P Niranjan Reddy; Qi Fan; Guiyun Yan; Jeeraphat Sirichaisinthop; Jetsumon Sattabongkot; Ananias A Escalante; Liwang Cui
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.